Zimmer Holdings, Inc. has recently come under scrutiny regarding reports of problems in a small percentage of their NexGen line of knee implants. This scrutiny follows the findings of two orthopedic surgeons who performed a retrospective analysis of patients who have been implanted with Zimmer’s NexGen CR-Flex and the Zimmer NexGen Total Knee Solutions Minimally Invasive model. These reports can be found on our Articles and Information page.
While the vast majority of the Zimmer NexGen product line is not the subject of the studies referenced above, there has been some anticipated litigation involving isolated components. If you are one of the few patients who has been implanted with one of the devices indicated above and you are experiencing pain, you should first consult your doctor to determine whether or not there is any problem with your implant. Your doctor may recommend that you undergo x-rays which may or may not show radiographic loosening similar to that which has been reported in the studies above.
In addition, you should contact the Mininno Law Office to determine whether or not you have any legal rights regarding these particular Zimmer NexGen knee implant components.
Latest Zimmer Knee Replacement News
- April 21
Knee Replacement Lawyers Explain Knee Replacement Surgery
- April 19
Knee Replacement Lawyers Warn About Post-Surgery Blood Clots
- April 15
Knee Replacements not always the Smart Choice
- April 12
Knee Replacement Lawyers: Learning to Walk Again
- April 12
Knee Replacement Lawyers: Implant Failure Brings Pain
We are private attorneys and not affliated with the manufacturer Zimmer, Inc. Product Identification Notice
In any of our web pages referring to Zimmer NexGen products, these pages are intended to provide information about and are referring to the same Zimmer products that were identified by Dr. Berger in his presentation and study entitled “The High Failure Rate of a High-Flex Total Knee Arthroplasty Design,” and were written about in the NY Times article titled “Surgeon vs. Knee Maker: Who’s Rejecting Whom?,” and that are reported in the FDA MAUDE database, where reports involving the Zimmer NexGen CR Flex Cementless or Porous Femoral Component can be found and also those products associated with aseptic loosening of the Zimmer MIS Tibial Component that led certain doctors to discontinue its use, and to recommend discontinued use of this product in primary TKA until the etiology of the high early failure rate of this implant is determined.
See prospective studies comparing the results of the Zimmer MIS Tibial Component using conventional and minimally invasive exposures as well as comparing fixation with different types of bone cement as described in Early Aseptic Loosening With a Precoated Low-Profile Tibial Component A Case Series. Not all Zimmer NexGen products are involved in our investigations and lawsuits.
|(c) Copyright 2011 Mininno Law Office|